Navigation Links
Novartis Drug Afinitor® Effective in Patients With Non-Cancerous Kidney Tumors Associated With TSC in Phase III Trial
Date:9/23/2011

ce. July 2011, Washington, D.C.
  • Harabayashi, et al. Management of renal angiomyolipomas associated with Tuberous Sclerosis Complex. J Urol 2004;171(1):102-105.
  • Singer. Angiomyolipoma. Available at http://www.medscape.com/viewarticle/415099.  Accessed September 2011.
  • Motzer, et al. Phase 3 Trial of Everolimus for Metastatic Renal Cell Carcinoma. Cancer 2010 Sep;116(18):4256-4265.
  • Krueger, et al. Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis. New Eng J Med 2010;363:1801-11.
  • US National Institutes of Health. Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) (EXIST-2). Available at: http://clinicaltrials.gov/ct2/show/NCT00790400?term=exist-2&rank=1.  Accessed September 2011.

  • Novartis Media RelationsMedia only:Investors only:Nicole Riley

    Richard JarvisNovartis Oncology

    Novartis CorporationP: +1 862 778 3110

    P: +1 212 830 2433Dana Kahn Cooper

    investor.relations@novartis.comP: +1 732 817 1800F: +1 732 817 1834For Novartis multimedia content, please visit www.thenewsmarket.com/Novartis

    For questions about the site or required registration, please contact: journalisthelp@thenewsmarket.com.


    '/>"/>

    SOURCE Novartis Pharmaceuticals Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Novartis Study Showed ACZ885 Provided Substantial Symptom Relief in 84% of Patients With the Most Serious Form of Childhood Arthritis
    2. Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
    3. Novartis Drug Gleevec® Shows Significant Overall Survival Benefit for Patients With GIST After Three Years of Adjuvant Treatment vs. One Year
    4. Novartis highlights extensive data on numerous compounds at ASCO in multiple cancers, including Phase III studies in GIST and myelofibrosis
    5. Novartis Data Shows ACZ885 for Severe Gouty Arthritis Provided Better Pain Relief and Reduced Risk of New Attacks by Up to 68% vs. Steroid
    6. FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors
    7. Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET
    8. Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin
    9. US Supreme Court Denies Certiorari and Thereby Leaves in Place Second Circuit Ruling That Novartis Pharmaceuticals Corporation Must Pay its Sales Representatives Overtime Compensation
    10. Novartis Gains FDA Approval for Amturnide™, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications
    11. Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... , Jan. 15, 2014  In an unprecedented effort to curb the ... ambulances and other transport vehicles, an advanced and portable UV germicidal ... for the first time. In order to prevent ... deadly pathogens, West Palm Beach Fire Rescue ...
    (Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
    (Date:1/15/2014)... NEW YORK , Jan. 15, ... new market research report is available ... Global Markets and Technologies for ... on Routes of Administration ...
    Breaking Medicine Technology:Superbugs No Longer Ride In Rescue Vehicles 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
    (Date:4/21/2014)... consider ways to ease prohibitions on marijuana, the public ... the past century may provide valuable lessons, according to ... legalized marijuana in Colorado and Washington for recreational uses ... to best allow the production, sales and the use ... social ills. , A new study published online by ...
    (Date:4/20/2014)... type of cell in the lining of the bladder ... according to researchers at the Stanford University School of ... first to pinpoint the normal cell type that can ... first to show that most bladder cancers and their ... explains why many human bladder cancers recur after therapy. ...
    (Date:4/18/2014)... University School of Medicine researchers have been awarded two-year ... Novo Nordisk announced this month. Of the 110 initial ... Biologics Science Forum Program, only four projects were funded, ... They are Jonathan Powell, M.D., Ph.D.; G. William Wong, ... Powell, a professor of oncology, will use his $500,000 ...
    (Date:4/18/2014)... available in French . ... practice and regenerative medicine. A team led by Ludwik ... Paris Tech) and Didier Letourneur from the Laboratoire Recherche ... just demonstrated that the principle of adhesion by aqueous ... repair soft-tissue organs and tissues. This easy-to-use gluing method ...
    (Date:4/17/2014)... pain relief targets that could be used to ... King,s College London made the discovery when researching ... of the body. , Dr Marzia Malcangio said: ... pain generation and our findings could help chemotherapy ... One potential side effect of some chemotherapy drugs ...
    Breaking Medicine News(10 mins):Health News:Regulating legal marijuana could be guided by lessons from alcohol and tobacco, study says 2Health News:Stanford scientists identify source of most cases of invasive bladder cancer 2Health News:Stanford scientists identify source of most cases of invasive bladder cancer 3Health News:Stanford scientists identify source of most cases of invasive bladder cancer 4Health News:Stanford scientists identify source of most cases of invasive bladder cancer 5Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:New pain relief targets discovered 2
    ... Free Support Magazine Helps Individuals and Families Embrace Life to ... N.J., Dec. 5 ConvaTec, a world-leading developer and marketer ... today the launch of ConTact, the new global lifestyle magazine ... with practical advice and feature articles on living a healthy ...
    ... 5 Empire BlueCross BlueShield today,announced that its employees ... 2008 Associate Giving Campaign. This amount is the,result ... match from the,WellPoint Foundation, Inc. , ... and health services,organizations are especially in need of help," ...
    ... Call on BCBS and OPM to Restore 2008 Benefits, Extend "Open Season" ... , Affected Patients and Doctors Available to ... , WASHINGTON, Dec. 5 Tick, Tick, Tick! Nearly half ... 8th to either change health care plans or face some costly penalties ...
    ... SEYMOUR, Tenn., Dec. 5 For many, city ... The usual hustle and bustle is further,glamorized by ... crowds,eager to soak in the joyful atmosphere. However, ... can be an emotionally trying time,filled with expectations ...
    ... N.J., Dec. 5 World Gourmet Marketing, LLC, creator,of the ... healthier,snack alternatives at the concession stands of the IZOD CENTER. ... when obesity is a national concern, the Nets are recognizing ... offerings,include: World Gourmet,s Sensible Portions Multi Grain Crisps, which are,baked, ...
    ... 5 /PRNewswire-FirstCall/ - DiagnoCure Inc. (TSX: CUR), a life ... laboratory services, announced today that the Company will release ... on December 17, 2008, at approximately 5:00 p.m. (ET). ... which will be held on December 18, 2008, at ...
    Cached Medicine News:Health News:ConvaTec Launches New Lifestyle Magazine for People With an Ostomy 2Health News:Empire BlueCross BlueShield Associates Commit Over $1 Million to Community Organizations in 2008 2Health News:Clock Ticking for Millions of Federal Employees Hoping to Avoid Blue Cross/Blue Shield Benefits Cut 2Health News:Single in the City? How the Holidays Leave the Fabulous Feeling More Like Failures 2Health News:Single in the City? How the Holidays Leave the Fabulous Feeling More Like Failures 3Health News:Nets Provide Fans with Healthy In-Game Snack Option 2Health News:DiagnoCure announces fourth quarter and full year 2008 earnings conference call and webcast 2
    Hydrophilic Acrylic Intraocular Lens, AC depth: 4.65....
    The STAAR ELASTIC LENS®, is a single piece silicone lens to be placed completely in the capsular bag....
    ... The Bausch & Lomb SoFlex™ ... Lenses are intended to be ... the visual correction of aphakia ... age or older where a ...
    Liberty Three Piece PMMA Lens with UV Absorber....
    Medicine Products: